Detection and occurrence of plasmid-mediated AmpC in highly resistant gram-negative Rods

PLoS ONE

Volumn 9, Issue 3, 2014, Pages

  Reuland, E Ascelijn ^a   Hays, John P ^b   De Jongh, Denise M C ^b   Abdelrehim, Eman ^a   Willemsen, Ina ^c   Kluytmans, Jan A J W ^a,c   Savelkoul, Paul H M ^a   Vandenbroucke Grauls, Christina M J E ^a   Naiemi, Nashwan Al ^a,d,e  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c AMPHIA HOSPITAL   (Netherlands)

^d Laboratory for Medical Microbiology and Public Health   (Netherlands)

^e TWENTEBORG HOSPITAL   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BETA LACTAMASE AMPC; BORONIC ACID DERIVATIVE; CEFOTAXIME; CEFOTETAN; CEFOXITIN; CEFTAZIDIME; CEPHALOSPORIN; CLOXACILLIN; AMPC BETA-LACTAMASES; ANTIINFECTIVE AGENT; BACTERIAL PROTEIN; BETA LACTAMASE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; CONTROLLED STUDY; ENTEROBACTERIACEAE; ENZYME ANALYSIS; EPSILOMETER TEST; ESCHERICHIA COLI; KLEBSIELLA OXYTOCA; KLEBSIELLA PNEUMONIAE; MOLECULAR EPIDEMIOLOGY; MULTIPLEX POLYMERASE CHAIN REACTION; NONHUMAN; PHENOTYPE; PLASMID; POLYMERASE CHAIN REACTION; PROTEUS MIRABILIS; SALMONELLA; SCREENING TEST; SENSITIVITY AND SPECIFICITY; SHIGELLA; SINGLEPLEX POLYMERASE CHAIN REACTION; BACTERIUM IDENTIFICATION; CLINICAL TRIAL; DISK DIFFUSION; DRUG EFFECTS; ENTEROBACTERIACEAE INFECTIONS; ENZYMOLOGY; EPIDEMIOLOGY; GENETICS; HUMAN; ISOLATION AND PURIFICATION; METABOLISM; MICROBIOLOGY; MULTICENTER STUDY; NETHERLANDS; PREVALENCE;

ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BACTERIAL TYPING TECHNIQUES; BETA-LACTAM RESISTANCE; BETA-LACTAMASES; CEFOTAXIME; CEFOTETAN; CEFOXITIN; CEFTAZIDIME; CLOXACILLIN; DISK DIFFUSION ANTIMICROBIAL TESTS; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTIONS; HUMANS; NETHERLANDS; PLASMIDS; PREVALENCE;

EID: 84898650553     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0091396     Document Type: Article

References (39)

1. NNIS (2004) National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004. Am J Infect Control 32: 470-485.
2. Kluytmans MF, Kluytmans JA, Voss A (2005) Dutch guideline for preventing nosocomial transmission of hi (Pubitemid 41552005)
3. Jacoby GA (2009) AmpC beta-lactamases. Clin Microbiol Rev 22: 161-182, Table of Contents.
4. Pitout JD (2012) Extraintestinal pathogenic Escherichia coli: an update on antimicrobial resistance, laboratory diagnosis and treatment. Expert Rev Anti Infect Ther 10: 1165-1176.
5. Pitout JD (2013) Enterobacteriaceae that produce extended-spectrum betalactamases and AmpC beta-lactamases in the community: the tip of the iceberg? Curr Pharm Des 19: 257-263.
6. Rodriguez-Bano J, Miro E, Villar M, Coelho A, Gozalo M, et al. (2012) Colonisation and infection due to Enterobacteriaceae producing plasmidmediated AmpC beta-lactamases. J Infect 64: 176-183.
7. Dahmen S, Mansour W, Charfi K, Boujaafar N, Arlet G, et al. (2012) Imipenem resistance in Klebsiella pneumoniae is associated to the combination of plasmidmediated CMY-4 AmpC beta-lactamase and loss of an outer membrane protein. Microb Drug Resist 18: 479-483.
8. Gude MJ, Seral C, Saenz Y, Cebollada R, Gonzalez M, et al. (2013) Molecular epidemiology, resistance profiles and clinical features in clinical plasmid-mediated AmpC-producing Enterobacteriaceae. Int J Med Microbiol.
9. Seiffert SN, Hilty M, Kronenberg A, Droz S, Perreten V, et al. (2013) Extendedspectrum cephalosporin-resistant Escherichia coli in community, specialized outpatient clinic and hospital settings in Switzerland. J Antimicrob Chemother 68: 2249-2254.
10. Miro E, Aguero J, Larrosa MN, Fernandez A, Conejo MC, et al. (2013) Prevalence and molecular epidemiology of acquired AmpC beta-lactamases and carbapenemases in Enterobacteriaceae isolates from 35 hospitals in Spain. Eur J Clin Microbiol Infect Dis 32: 253-259.
11. Voets GM, Platteel TN, Fluit AC, Scharringa J, Schapendonk CM, et al. (2012) Population distribution of Beta-lactamase conferring resistance to thirdgeneration cephalosporins in human clinical Enterobacteriaceae in the Netherlands. PLoS One 7: e52102.
12. Dierikx C, van der Goot J, Fabri T, van Essen A, Smith H, et al. (2013) Extended-spectrum-beta-lactamase- and AmpC-beta-lactamase-producing Escherichia coli in Dutch broilers and broiler farmers. J Antimicrob Chemother 68: 60-67.
13. Perez-Perez FJ, Hanson ND (2002) Detection of plasmid-mediated AmpC betalactamase genes in clinical isolates by using multiplex PCR. J Clin Microbiol 40: 2153-2162. (Pubitemid 34596400)
14. Gude MJ, Seral C, Saenz Y, Gonzalez M, Torres C, et al. (2012) Evaluation of four phenotypic methods to detect plasmid-mediated AmpC betalactamases in clinical isolates. Eur J Clin Microbiol Infect Dis 31: 2037-2043.
15. Black JA, Moland ES, Thomson KS (2005) AmpC disk test for detection of plasmid-mediated AmpC beta-lactamases in Enterobacteriaceae lacking chromosomal AmpC beta-lactamases. J Clin Microbiol 43: 3110-3113. (Pubitemid 40981309)
16. Doi Y, Paterson DL (2007) Detection of plasmid-mediated class C betalactamases. Int J Infect Dis 11: 191-197.
17. Willemsen I, Elberts S, Verhulst C, Rijnsburger M, Filius M, et al. (2011) Highly resistant gram-negative microorganisms: incidence density and occurrence of nosocomial transmission (TRIANGLe Study). Infect Control Hosp Epidemiol 32: 333-341.
18. al Naiemi N, Cohen Stuart J, Leverstein M (2008) NVMM guideline of the Dutch Society for Medical Microbiology for screening and confirmation of extended-spectrum beta-lactamases (ESBLs) in Enterobacteriaceae [in Dutch]. http://www.nvmm.nl/richtlijnen/esbl.
19. Willemsen I, Overdevest I, Al Naiemi N, Rijnsburger M, Savelkoul P, et al. (2011) New diagnostic microarray (Check-KPC ESBL) for detection and identification of extended-spectrum beta-lactamases in highly resistant Enterobacteriaceae. J Clin Microbiol 49: 2985-2987.
20. Naiemi NA, Duim B, Savelkoul PH, Spanjaard L, de Jonge E, et al. (2005) Widespread transfer of resistance genes between bacterial species in an intensive care unit: implications for hospital epidemiology. J Clin Microbiol 43: 4862-4864. (Pubitemid 41298296)
21. EUCAST European Committee on Antimicrobial Susceptibility Testing Breakpoint tables for interpretation of MICs and zone diameters Version 20, valid from 2012-01-01 [Accessed: November, 2012] Växjö : EUCAST Available: http://wwweucastorg/fileadmin/src/media/PDFs/EUCASTfiles/ Breakpointtables/Breakpointtablev20pdf.
22. Savelkoul PH, Aarts HJ, de Haas J, Dijkshoorn L, Duim B, et al. (1999) Amplified-fragment length polymorphism analysis: the state of an art. J Clin Microbiol 37: 3083-3091. (Pubitemid 29455186)
23. Cohen Stuart J, Leverstein M, al Naiemi N (2012) NVMM Guideline Laboratory detection of highly resistant microorganisms, version 2.0. Available: http://www.nvmm.nl/richtlijnen/hrmo-laboratory-detection-highly- resistantmicroorganisms.
24. Pitout JD, Gregson DB, Church DL, Laupland KB (2007) Population-based laboratory surveillance for AmpC beta-lactamase-producing Escherichia coli, Calgary. Emerg Infect Dis 13: 443-448. (Pubitemid 46348131)
25. Woodford N, Reddy S, Fagan EJ, Hill RL, Hopkins KL, et al. (2007) Wide geographic spread of diverse acquired AmpC beta-lactamases among Escherichia coli and Klebsiella spp. in the UK and Ireland. J Antimicrob Chemother 59: 102-105. (Pubitemid 46017908)
26. Nadjar D, Rouveau M, Verdet C, Donay L, Herrmann J, et al. (2000) Outbreak of Klebsiella pneumoniae producing transferable AmpC-type beta-lactamase (ACC-1) originating from Hafnia alvei. FEMS Microbiol Lett 187: 35-40. (Pubitemid 30316452)
27. Ohana S, Leflon V, Ronco E, Rottman M, Guillemot D, et al. (2005) Spread of a Klebsiella pneumoniae strain producing a plasmid-mediated ACC-1 AmpC beta-lactamase in a teaching hospital admitting disabled patients. Antimicrob Agents Chemother 49: 2095-2097. (Pubitemid 40631629)
28. Huang IF, Chiu CH, Wang MH, Wu CY, Hsieh KS, et al. (2005) Outbreak of dysentery associated with ceftriaxone-resistant Shigella sonnei: First report of plasmid-mediated CMY-2-type AmpC beta-lactamase resistance in S. sonnei. J Clin Microbiol 43: 2608-2612.
29. Pai H, Kang CI, Byeon JH, Lee KD, Park WB, et al. (2004) Epidemiology and clinical features of bloodstream infections caused by AmpC-type-beta-lactamase- producing Klebsiella pneumoniae. Antimicrob Agents Chemother 48: 3720-3728. (Pubitemid 39304595)
30. Naseer U, Haldorsen B, Simonsen GS, Sundsfjord A (2010) Sporadic occurrence of CMY-2-producing multidrug-resistant Escherichia coli of ST-complexes 38 and 448, and ST131 in Norway. Clin Microbiol Infect 16: 171-178.
31. Tan TY, Ng SY, Teo L, Koh Y, Teok CH (2008) Detection of plasmid-mediated AmpC in Escherichia coli, Klebsiella pneumoniae and Proteus mirabilis. J Clin Pathol 61: 642-644. (Pubitemid 351678220)
32. Hernandez-Alles S, Conejo M, Pascual A, Tomas JM, Benedi VJ, et al. (2000) Relationship between outer membrane alterations and susceptibility to antimicrobial agents in isogenic strains of Klebsiella pneumoniae. J Antimicrob Chemother 46: 273-277. (Pubitemid 30639298)
33. Poirel L, Naas T, Nicolas D, Collet L, Bellais S, et al. (2000) Characterization of VIM-2, a carbapenem-hydrolyzing metallo-beta-lactamase and its plasmid- and integron-borne gene from a Pseudomonas aeruginosa clinical isolate in France. Antimicrob Agents Chemother 44: 891-897. (Pubitemid 30165266)
34. Mulvey MR, Bryce E, Boyd DA, Ofner-Agostini M, Land AM, et al. (2005) Molecular characterization of cefoxitin-resistant Escherichia coli from Canadian hospitals. Antimicrob Agents Chemother 49: 358-365. (Pubitemid 40065813)
35. Mata C, Miro E, Rivera A, Mirelis B, Coll P, et al. (2010) Prevalence of acquired AmpC beta-lactamases in Enterobacteriaceae lacking inducible chromosomal ampC genes at a Spanish hospital from 1999 to 2007. Clin Microbiol Infect 16: 472-476.
36. Naiemi NA, Murk JL, Savelkoul PH, Vandenbroucke CM, Debets YJ (2009) Extended-spectrum beta-lactamases screening agar with AmpC inhibition. Eur J Clin Microbiol Infect Dis 28: 989-990.
37. Beesley T, Gascoyne N, Knott-Hunziker V, Petursson S, Waley SG, et al. (1983) The inhibition of class C beta-lactamases by boronic acids. Biochem J 209: 229-233. (Pubitemid 13153654)
38. Yagi T, Wachino J, Kurokawa H, Suzuki S, Yamane K, et al. (2005) Practical methods using boronic acid compounds for identification of class C betalactamase- producing Klebsiella pneumoniae and Escherichia coli. J Clin Microbiol 43: 2551-2558. (Pubitemid 40827918)
39. Tan TY, Ng LS, He J, Koh TH, Hsu LY (2009) Evaluation of screening methods to detect plasmid-mediated AmpC in Escherichia coli, Klebsiella pneumoniae, and Proteus mirabilis. Antimicrob Agents Chemother 53: 146-149.